Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2005-002679-34-DK
EUCTR2005-002679-34-DK
Active, not recruiting
Phase 1

The effect of LH priming in early follicular phase on the endocrinological function of the ovary and pregnancy rate in GnRh downregulated women stimulated by exogen gonadotophins in IVF-treatment

The Fertility Clinic, Sygehus Viborg (Skive)0 sites150 target enrollmentOctober 11, 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsMenopurPuregon cylinderampul 600IEPuregon cylinderampul 300IE

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
The Fertility Clinic, Sygehus Viborg (Skive)
Enrollment
150
Status
Active, not recruiting
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 11, 2005
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Sponsor
The Fertility Clinic, Sygehus Viborg (Skive)

Eligibility Criteria

Inclusion Criteria

  • •Women aged 18\- 38 years in IVF\-treatment
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) no
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Male infertility with low sperm count necessitating microinsemination for fertilization

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
Phase 4
The Effect of LH-Priming During Early Follicular Phase in IVF Treatment.Infertility
NCT00334425Central Jutland Regional Hospital150
Active, not recruiting
Not Applicable
Androgen priming in the late luteal phase as a mean to improve the outcome of ovarian stimulation for IVF in normogonadotrophic women with a previously proven poor response - Androgen primingHypothesis. By combining pituitary downregulation with aromatase inhibitor, and hCG injection during a late luteal phase a powerful stimulation of thecal androgen production is achieved. Thereby, it is expected that the later FSH stimulation will result in growth and pre-ovulatory development of significantly more follicles in women with a previously proven poor response to standard hormone treatment in IVF cycles. The present study is designed to meet these requirements.
EUCTR2005-003104-11-DKFertility clinic Odense University Hospital20
Completed
Phase 4
The efficacy of progestin primed ovarian stimulation (PPOS) during controlled ovarian stimulation(COS) for patients with endometriosisinfertility
JPRN-UMIN000031111Kamiya Ladies Clinic150
Completed
Phase 4
Early Follicular Supplementation of Ganirelix in IVF 2004InfertilityIVF Treatment
NCT00461422The Baruch Padeh Medical Center, Poriya50
Completed
Phase 3
Effect of luteal phase stimulation with follicular phase stimulation in poor ovarian response
IRCT20210405050852N1Avicenna University Jihad Infertility Center Avicenna78